Trademark Details For BRYMYNT (Serial Number 97287512)

  •  Home
  •  Print
BRYMYNT
1
3
2
0
word.basic_information
Serial Number  United States - USPTO 97287512
Registration Number -
Mark
BRYMYNT
Filing Date Feb-28-2022
Status
Pending  
THIRD EXTENS.. (732)
THIRD EXTENSION - GRANTED
Attorney Name
TTAB
0


  • TEVA PHARMACEUTICALS USA


005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameLaurence Rickles TEVA PHARMACEUTICALS USA, INC.
Address400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 United States

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Mar-03-2022NEW APPLICATION ENTERED   NWAPI
Mar-03-2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Sep-20-2022ASSIGNED TO EXAMINER   DOCKD
Sep-26-2022APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Oct-12-2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Nov-01-2022PUBLISHED FOR OPPOSITION   PUBOA
Nov-01-2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Dec-27-2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Jun-21-2023SOU TEAS EXTENSION RECEIVED   EEXTI
Jun-21-2023SOU EXTENSION 1 FILED   EXT1S
Jun-21-2023SOU EXTENSION 1 GRANTED   EX1GS
Jun-23-2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Dec-21-2023SOU TEAS EXTENSION RECEIVED   EEXTI
Dec-21-2023SOU EXTENSION 2 FILED   EXT2S
Dec-21-2023SOU EXTENSION 2 GRANTED   EX2GS
Dec-23-2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Jun-06-2024SOU TEAS EXTENSION RECEIVED   EEXTI
Jun-06-2024SOU EXTENSION 3 FILED   EXT3S
Jun-06-2024SOU EXTENSION 3 GRANTED   EX3GS
Jun-13-2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE